1 During the same period, the rate of bariatric surgeries fell by nearly 42%, indicating a shift in how patients and physicians are managing obesity
"If anything, when we slow down the titration, we would expect the accountability to be even further improved," Chakravarthy told CNBC
However, those health improvements shouldnt come at the expense of your oral health
Published in JAMA Psychiatry, the study found that more than half of patients with binge eating disorder and one third of patients with atypical anorexia nervosa reported having used GLP-1 medications
Effect of Glycemia on Plasma Incretins and the Incretin Effect During Oral Glucose Tolerance Test
Protecting patients and trust The dangers are abundantly clear: a poorly regulated peptide market awash with misinformation will set back progress in obesity medication by years and put people in danger